Rapid and Early Onset of Itch Relief with Tapinarof Cream 1% Once Daily in Two Pivotal Phase 3 Trials in Adults and Children Down to Two Years of Age with Atopic Dermatitis

Main Article Content

Eric Simpson
Jonathan I. Silverberg
Robert Bissonnette
Linda Stein Gold
April Armstrong
Adelaide A. Hebert
Rocco T. Serrao
Jeannette R. Jakus
Philip M. Brown
David S. Rubenstein
Stephen C. Piscitelli
Anna Tallman
Lawrence F. Eichenfield


atopic dermatitis, eczema, tapinarof cream 1% once daily, itch, pruritus, PP-NRS, AhR agonist


1. Silverberg JI, et al. Ann Allergy Asthma Immunol. 2018;121:340–347.

2. LeBovidge JS, et al. J Pediatr Psychol. 2007;32:617–625.

3. Meltzer LJ, et al. Ann Allergy Asthma Immunol. 2020;124:385–392.

4. Birdi G, et al. Int J Dermatol. 2020;59:e75–e91.

5. Dermavant Sciences. VTAMA (tapinarof) cream, 1%: US prescribing information. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215272s000lbl.pdf. Accessed September 2023.

6. Kircik L, et al. Poster at the Winter Clinical Dermatology Conference, January 13–18, 2023.

7. Peppers J, et al. J Am Acad Dermatol. 2019;80:89–98.

8. Paller AS, et al. J Am Acad Dermatol. 2021;84:632–638.

9. Silverberg JI, et al. Presentation at the European Academy of Dermatology and Venereology, October 11–14, 2023.

10. Yosipovitch G, et al. Br J Dermatol. 2019;181:761–769.

11. Blauvelt A, et al. J Eur Acad Dermatol Venereol. 2023;37:137–146.

12. Silverberg JI, et al. Br J Dermatol. 2020;183:891–898.

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>